Logo
Login
$VCYT
$50.28 +$2.08 (4.32%) Close

Company Executives

$VCYT Management Team

Mr. John Leite

Global Chief Commercial Officer

Age 53
Compensation $3.094M USD
Sex Male

Dr. Robert Epstein

Independent Chairman of the Board

Age 70
Compensation $360.0K USD
Sex Male

Mr. Marc Stapley

Chief Executive Officer

Director

Age 55
Compensation $6.816M USD
Sex Male

Ms. Rebecca Chambers

Chief Financial Officer

Age 47
Compensation $3.645M USD
Sex Female

Ms. Annie Mcguire

Chief Human Resources Officer

General Counsel

Age 45
Compensation $3.091M USD
Sex Female

Dr. Phillip Febbo

Chief Scientific Officer

Chief Medical Officer

Age 58
Compensation $2.790M USD
Sex Male

Board of Directors

From the proxy statement filed Apr 22, 2026
Directors
9
serving now
Independent
0 of 1
stated in the proxy; 8 not stated
Average tenure
7.4 years
from year joined
CEO also chairs the board
No
Robert S. Epstein
Director Age On board Independent Committees Other public boards 2025 pay Source
Marc Stapley
CEO
 56 2021
5 years
 Not independent None stated Glaukos Corporation Paid as CEO
Eliav Barr
61 2022
4 years
 Not stated None stated None stated $304,989
Muna Bhanji
63 2021
5 years
 Not stated None stated Intellia Therapeutics, Inc., Cytokinetics, Inc., Ardelyx, Inc. $309,989
Karin Eastham
76 2012
14 years
 Not stated
Compensation · Chair
Personalis, Inc. $324,989
Robert S. Epstein
Board chair
 70 2015
11 years
 Not stated
Nominating and Corporate Governance · Chair
Fate Therapeutics, Inc., Illumina, Inc. $359,989
Jens Holstein
62 2020
6 years
 Not stated
Audit · Chair
None stated $327,489
Evan Jones
69 2008
18 years
 Not stated
Regulatory and Compliance · Chair
None stated $324,989
Tom Miller
47 2024
2 years
 Not stated None stated None stated $304,989
Brent Shafer
68 2024
2 years
 Not stated None stated Baxter International, Inc. $307,489

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 22, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans